Focused on the intersection of tech and biotech, speed thrills Foresite Capital’s new $969M fund
The founder and CEO of the venture capital firm, which has backed fast-moving companies at the intersection of tech and biotech, talks about its fifth fund, SPACs and the wealth of cycle-experienced entrepreneurs.